Patients hospitalized during the COVID-19 pandemic and tested for SARS-CoV-2 had higher rates of antibiotic-resistant infections compared with those hospitalized before the pandemic, according to a study presented yesterday at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022).
Data from the Wellcome Monitor survey of UK citizens reveal that negative views of vaccination are tied to having poor knowledge about the role of antibiotics for treating infections, according to a study today in Vaccine.
A large-scale analysis reveals that the prevalence of antimicrobial resistance (AMR) has remained stable for Campylobacter in the United States and United Kingdom in recent years, suggesting that antibiotic stewardship efforts have not made a large impact, according to a new study in Antimicrobial Agents and Chemotherapy.
A study conducted at five acute care hospitals adds further evidence of the role the hospital environment plays in Clostridioides difficile infection (CDI), researchers reported today in the American Journal of Infection Control.
A review of Clostridioides difficile infection (CDI) treatments at 10 community hospitals found that only 50% of treatment regimens were adherent to guidelines regarding use of fidaxomicin, researchers reported today in Infection Control & Hospital Epidemiology.
In a phase 3 trial, an investigational oral microbiome therapy was superior to placebo in reducing the risk of recurrent Clostridioides difficile infection, researchers reported yesterday in the New England Journal of Medicine.
Implementation of a multifaceted antimicrobial stewardship program (ASP) in a large community hospital in New Jersey was associated with significant, sustained reductions in unnecessary antibiotic use, Clostridioides difficile infection (CDI) rates, and antimicrobial acquisition costs, researchers reported late last week in Infection Control & Hospital Epidemiology.
A new report from the Centers for Disease Control and Prevention (CDC) shows that progress against healthcare-associated infections (HAIs), including those caused by antibiotic-resistant bacteria, took a step back in 2020.
A pair of values-based incentive programs at US hospitals were linked to a decline in C difficile.
Implementing institution-specific guidelines (ISGs) for antimicrobial prescribing and use of diagnostics at a tertiary care hospital was associated with significant declines in antibiotic resistance rates and Clostridioides difficile infections (CDIs), German researchers reported yesterday in PLOS One.